SLC38A1 and triple-negative breast carcinoma: Other glutamine transporters such as SNAT1 (SLC38A1) and SNAT2 (SLC38A2) have also been shown to play a role in glutamine uptake in triple-negative breast cancer [14], and in osteosarcoma and cervical cancer cells [16].